Analysis of risk factors of prolonged mechanical ventilation after lung transplantation
-
摘要:
目的 探讨肺移植受者术后机械通气延长(PMV)的危险因素。 方法 回顾性分析90例肺移植受者的临床资料。根据术后有创机械通气时间分为PMV组(通气时间 > 48 h,30例)和对照组(通气时间≤48 h,60例)。比较两组受者围手术期相关指标,包括术前指标[血清肌酐、估算肾小球滤过率(eGFR)],术中指标(供肺冷缺血时间、出血量),术后指标[首次红细胞、白细胞、血小板计数、血红蛋白、C-反应蛋白、血清肌酐、总胆红素、丙氨酸转氨酶(ALT)、氧合指数、eGFR、入重症监护室(ICU)平均动脉压]。采用多因素logistic层次回归分析肺移植受者术后PMV的危险因素。 结果 PMV组受者术前血清肌酐为62(53,67)μmol/L,高于对照组受者的57(47,62)μmol/L;PMV组受者术前eGFR为97(93,107)mL/min,低于对照组受者的106(102,116)mL/min;PMV组受者术后首次氧合指数为196(157, 286)mmHg,低于对照组受者的250(199,354)mmHg(均为P < 0.05)。多因素分析显示术后首次总胆红素升高、术后首次氧合指数和术前eGFR降低是肺移植术后PMV的独立危险因素。 结论 术后首次总胆红素升高、术后首次氧合指数和术前eGFR降低是肺移植术后PMV的独立危险因素。 Abstract:Objective To identify the risk factors of prolonged mechanical ventilation (PMV) after lung transplantation. Methods Clinical data of 90 recipients undergoing lung transplantation were retrospectively analyzed. According to the duration of invasive mechanical ventilation after operation, all recipients were divided into the PMV group (ventilation duration > 48 h, n=30) and control group (ventilation duration≤48 h, n=60). Perioperative parameters were compared between two groups, including preoperative parameters [serum creatinine, estimated glomerular filtration rate (eGFR)], intraoperative parameters (cold ischemia time of donor lung, blood loss), and postoperative parameters [the first red blood cell, white blood cell, platelet count, hemoglobin, C-reactive protein, serum creatinine, total bilirubin, alanine aminotransferase (ALT), oxygenation index, eGFR and the mean arterial pressure in intensive care unit (ICU)]. The risk factors of PMV after lung transplantation were assessed by multivariate logistic regression analysis. Results Preoperative serum creatinine level in the PMV group was 62 (53, 67) μmol/L, significantly higher than 57 (47, 62) μmol/L in the control group. Preoperative eGFR in the PMV group was 97 (93, 107) mL/min, significantly lower than 106 (102, 116) mL/min in the control group. The first postoperative oxygenation index in the PMV group was 196 (157, 286) mmHg, significantly lower than 250 (199, 354) mmHg in the control group (all P < 0.05). Multivariate analysis showed that the first increase of postoperative total bilirubin, the first decrease of postoperative oxygenation index and preoperative eGFR decrease were the independent risk factors for PMV following lung transplantation. Conclusions The first increase of postoperative total bilirubin, the first decrease of postoperative oxygenation index and preoperative eGFR decrease are the independent risk factors for PMV after lung transplantation. -
表 1 两组受者围手术期相关指标的比较
Table 1. Comparison of perioperative indexes of recipients between the two groups[M(P25, P75)]
指标 对照组(n=60) PMV组(n=30) P值 术前指标 血清肌酐(μmol/L) 57(47,62) 62(53,67) 0.026 eGFR(mL/min) 106(102,116) 97(93,107) 0.001 术中指标 供肺冷缺血时间(min) 515(420,598) 470(379,562) 0.072 出血量(mL) 1 000(800,1 500) 1 150(800,1 500) 0.322 术后指标 首次红细胞(×1012/L) 4(3,4) 4(3,4) 0.976 首次白细胞(×109/L) 12(8,16) 11(7,15) 0.344 首次血小板计数(×109/L) 138(116,174) 130(94,156) 0.153 首次血红蛋白(g/L) 110(100,122) 109(102,122) 0.834 首次C-反应蛋白(mg/L) 7(4,15) 6(3,16) 0.722 首次血清肌酐(μmol/L) 55(47,66) 57(45,65) 0.894 首次总胆红素(μmol/L) 28(22,36) 40(22,50) 0.055 首次ALT(U/L) 30(21,34) 24(19,33) 0.200 首次氧合指数(mmHg) 250(199,354) 196(157,286) 0.008 首次eGFR(mL/min) 103(97,113) 102(91,115) 0.480 入ICU平均动脉压(mmHg) 84(73,96) 79(72,86) 0.202 表 2 模型拟合的评价分析
Table 2. Evaluation and analysis of model fitting
模型 离差 AIC① BIC② 模型对比 对比模型 χ2 P值 1 109.3 113 118 2 102.4 108 116 1-2 6.911 0.009 3 96.8 105 115 2-3 5.6 0.018 4 96.4 106 119 3-4 0.363 0.547 5 94.5 107 122 4-5 1.93 0.165 注:①AIC为赤池信息准则。
②BIC为贝叶斯信息准则。表 3 肺移植术后PMV危险因素的多因素logistic回归分析结果
Table 3. Multivariate logistic regression analysis of PMV risk factors after lung transplantation
预测变量 系数① 标准误 Z值 P值 比值比 95% CI 术后首次总胆红素 0.043 20 0.019 34 2.23 0.026 1.044 1.005~1.084 术后首次氧合指数 -0.005 87 0.002 80 -2.10 0.036 0.994 0.989~0.999 术前eGFR -0.046 12 0.020 52 -2.25 0.025 0.955 0.917~0.994 注:①系数表示“是否通气时间延长= 1”与“是否通气时间延长= 0”相比的对数比。 -
[1] ROSE L, MCGINLAY M, AMIN R, et al. Variation in definition of prolonged mechanical ventilation[J]. Respir Care, 2017, 62(10): 1324-1332. DOI: 10.4187/respcare.05485. [2] MCCORT M, MACKENZIE E, PURSELL K, et al. Bacterial infections in lung transplantation[J]. J Thorac Dis, 2021, 13(11): 6654-6672. DOI: 10.21037/jtd-2021-12. [3] JOEAN O, WELTE T, GOTTLIEB J. Chest infections after lung transplantation[J]. Chest, 2022, 161(4): 937-948. DOI: 10.1016/j.chest.2021.10.014. [4] CAO S, TENNAKOON L, BRUBAKER AL, et al. Infection with two multi-drug-resistant organisms in solid organ transplant patients is associated with increased mortality and prolonged hospitalization[J]. Surg Infect (Larchmt), 2022, 23(4): 394-399. DOI: 10.1089/sur.2021.300. [5] FISHMAN JA. Infection in organ transplantation[J]. Am J Transplant, 2017, 17(4): 856-879. DOI: 10.1111/ajt.14208. [6] DI NARDO M, TIKKANEN J, HUSAIN S, et al. Postoperative management of lung transplant recipients in the intensive care unit[J]. Anesthesiology, 2022, 136(3): 482-499. DOI: 10.1097/ALN.0000000000004054. [7] BENNETT D, FOSSI A, MARCHETTI L, et al. Postoperative acute kidney injury in lung transplant recipients[J]. Interact Cardiovasc Thorac Surg, 2019, 28(6): 929-935. DOI: 10.1093/icvts/ivy355. [8] CLARK NM, WEIGT SS, FISHBEIN MC, et al. Fungal infections complicating lung transplantation[J]. Semin Respir Crit Care Med, 2018, 39(2): 227-254. DOI: 10.1055/s-0037-1617443. [9] LEASE ED, BUDEV MM. Infectious complications in lung transplant recipients[J]. Thorac Surg Clin, 2022, 32(2): 211-220. DOI: 10.1016/j.thorsurg.2021.12.002. [10] PAGLICCI L, BORGO V, LANZARONE N, et al. Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(6): 1271-1282. DOI: 10.1007/s10096-021-04153-1. [11] BEER A, REED RM, BÖLÜKBAS S, et al. Mechanical ventilation after lung transplantation. an international survey of practices and preferences[J]. Ann Am Thorac Soc, 2014, 11(4): 546-553. DOI: 10.1513/AnnalsATS.201312-419OC. [12] HADEM J, GOTTLIEB J, SEIFERT D, et al. Prolonged mechanical ventilation after lung transplantation-a single-center study[J]. Am J Transplant, 2016, 16(5): 1579-1587. DOI: 10.1111/ajt.13632. [13] HUSAIN-SYED F, FERRARI F, BIRK HW, et al. Pre-transplant renal functional reserve and renal function after lung transplantation[J]. J Heart Lung Transplant, 2020, 39(9): 970-974. DOI: 10.1016/j.healun.2020.05.011. [14] WEHBE E, BROCK R, BUDEV M, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation[J]. J Heart Lung Transplant, 2012, 31(3): 244-251. DOI: 10.1016/j.healun.2011.08.016. [15] DORICIC J, GREITE R, VIJAYAN V, et al. Kidney injury after lung transplantation: long-term mortality predicted by post-operative day-7 serum creatinine and few clinical factors[J]. PLoS One, 2022, 17(3): e0265002. DOI: 10.1371/journal.pone.0265002. [16] POTESTIO C, JORDAN D, KACHULIS B. Acute postoperative management after lung transplantation[J]. Best Pract Res Clin Anaesthesiol, 2017, 31(2): 273-284. DOI: 10.1016/j.bpa.2017.07.004. [17] HOEPER MM, BENZA RL, CORRIS P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801906. DOI: 10.1183/13993003.01906-2018. [18] MALBRAIN MLNG, LANGER T, ANNANE D, et al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA)[J]. Ann Intensive Care, 2020, 10(1): 64. DOI: 10.1186/s13613-020-00679-3. [19] TRINH BN, BRZEZINSKI M, KUKREJA J. Early postoperative management of lung transplant recipients[J]. Thorac Surg Clin, 2022, 32(2): 185-195. DOI: 10.1016/j.thorsurg.2021.11.006. [20] KALAS MA, CHAVEZ L, LEON M, et al. Abnormal liver enzymes: a review for clinicians[J]. World J Hepatol, 2021, 13(11): 1688-1698. DOI: 10.4254/wjh.v13.i11.1688. [21] CHAMBERS DC, CHERIKH WS, HARHAY MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38(10): 1042-1055. DOI: 10.1016/j.healun.2019.08.001. [22] VAN SLAMBROUCK J, VAN RAEMDONCK D, VOS R, et al. A focused review on primary graft dysfunction after clinical lung transplantation: a multilevel syndrome[J]. Cells, 2022, 11(4): 745. DOI: 10.3390/cells11040745. [23] CRINER RN, CLAUSEN E, CANTU E. Primary graft dysfunction[J]. Curr Opin Organ Transplant, 2021, 26(3): 321-327. DOI: 10.1097/MOT.0000000000000876. [24] LI D, WEINKAUF J, KAPASI A, et al. Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation[J]. Respir Med, 2021, 188: 106617. DOI: 10.1016/j.rmed.2021.106617. [25] 肖漓, 解立新, 石炳毅. 肺移植免疫学相关基础与临床研究进展[J]. 器官移植, 2021, 12(6): 637-642. DOI: 10.3969/j.issn.1674-7445.2021.06.001.XIAO L, XIE LX, SHI BY. Progress on basic and clinical research of immunology in lung transplantation[J]. Organ Transplant, 2021, 12(6): 637-642. DOI: 10.3969/j.issn.1674-7445.2021.06.001. [26] BELLIER J, LHOMMET P, BONNETTE P, et al. Extracorporeal membrane oxygenation for grade 3 primary graft dysfunction after lung transplantation: long-term outcomes[J]. Clin Transplant, 2019, 33(3): e13480. DOI: 10.1111/ctr.13480. [27] GEUBE M, ANANDAMURTHY B, YARED JP. Perioperative management of the lung graft following lung transplantation[J]. Crit Care Clin, 2019, 35(1): 27-43. DOI: 10.1016/j.ccc.2018.08.007. [28] WAJDA-POKRONTKA M, NADZIAKIEWICZ P, KRAUCHUK A, et al. Influence of fluid therapy on kidney function in the early postoperative period after lung transplantation[J]. Transplant Proc, 2022, 54(4): 1115-1119. DOI: 10.1016/j.transproceed.2022.02.021. [29] SCHULTZE BS. Fluid management in lung transplant patients[J]. Nurs Clin North Am, 2017, 52(2): 301-308. DOI: 10.1016/j.cnur.2017.01.007. [30] NATALINI JG, DIAMOND JM. Primary graft dysfunction[J]. Semin Respir Crit Care Med, 2021, 42(3): 368-379. DOI: 10.1055/s-0041-1728794. [31] 李基伟, 徐磊, 韩志军, 等. 肺移植术后原发性移植功能障碍风险因素的Logistic回归分析[J]. 中华医学杂志, 2018, 98(19): 1503-1506. DOI: 10.3760/cma.j.issn.0376-2491.2018.19.010.LI JW, XU L, HAN ZJ, et al. Logistic regression analysis of risk factors for primary graft dysfunction after lung transplantation[J]. Natl Med J China, 2018, 98(19): 1503-1506. DOI: 10.3760/cma.j.issn.0376-2491.2018.19.010. [32] WANG X, O'BRIEN ME, YU J, et al. Prolonged cold ischemia induces necroptotic cell death in ischemia-reperfusion injury and contributes to primary graft dysfunction after lung transplantation[J]. Am J Respir Cell Mol Biol, 2019, 61(2): 244-256. DOI: 10.1165/rcmb.2018-0207OC.